I am hopeful that you are right buddy. The pps needs some breathing room indeed.Over time, I am sure they will find a way to unlock true value of this behemoth: AMBS. The pipeline seems ripe for a move to final stages (ESS and Eltoprazine). MANF with all those eyes Orphan indications should and must be in the back burner. Move forward with something than can generate cash and nurture every else. Patience is virtue, blind patience is not wisdom.
I feel its a baby step in the right direction as well. My 1st interpretation was its a move closer to removing the toxic financing to long term and stable holders ....look at the 5-7 week window leading into March as a preclude to a larger financing deal.
Also, if Intl. Fuson is there to support the financing one way or another...thats a good thing too.